Question by rb_32368: I need the name of a in-patient drug treatment facility where my daughter can have her 4 week old son?
does anyone know of a drug treatment facility in washington state where new mothers can have thier baby stay at the facility with them? My daughter is a single mother, 20yrs old and my beautiful grandson is 4 weeks old. I want to keep them together if possible but there is no getting out of going to treatment for my daughter. it would be best for both of them to go together so please help with any info you may have. thank you very much for your time.
Best answer:
Answer by gypsy pirate
You are kidding aren’t you??
If your daughter has a drug habit bad enough to warrant going into a treatment facility I would want to keep my grandson well away from her until she gets her act together.
Was your grandson born with a drug habit as well?
Give your answer to this question below!
Men's health | Treatments for erectile dysfunction 'underutilized'
Filed under: drug rehab treatment options
Never mind the commercials with men talking freely to their doctor about their erectile dysfunction, taking a prescription for treatment to the pharmacy and settling in for a romantic evening. Despite a wide range of treatment options, most men with …
Read more on The Courier-Journal
Trius Announces Notice of Allowance of US Patent Application Related to …
Filed under: drug rehab treatment options
Tedizolid appears to be unique in this mutant prevention activity given that seven other medicines tested, including linezolid, the only other drug of the same class as tedizolid, failed to show the same mutant prevention activity. "MRSA bacteremia is …
Read more on GlobeNewswire (press release)
Speculation Sickens the Dow, Pharma Tries to Cure It
Filed under: drug rehab treatment options
Despite announcing a second recall of its thyroid-disease treatment Levoxyl for potency problems, the drugmaker is going higher today. The company is establishing online … As Viagra is one of the world's most counterfeited drugs, the online sales …
Read more on Motley Fool